Cav-1 inhibits the production of autophagic lysosomes by blocking the fusion of lysosomes and autophagosomes, thus blocking autophagic flow and inhibiting the proliferation of breast cancer cells (Shi et al., 2015). Here, CAV1 is linked to breast carcinoma.